Search results for: 'tech ad condition'

07 Dec 2017  |  North America  |  Market Research

Global Animal Feed Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Market, Forecast to 2021

Growing End-application Demand Induced by Rising Health Awareness

Infographics

×

Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) are essential nutrients but are not normally produced by animals in any significant quantity. Adding DHA + EPA to animal feed helps to enhance fertility, enhance sperm count, enhance the viability of young, improve skin conditions, improve growth rate, improve feed conversion, and increase ...

15 Mar 2018  |  North America  |  Market Outlook

Global Autonomous Driving Market Outlook, 2018

The Global Autonomous Driving Market is Expected Grow up to $173.15 B by 2030, with Shared Mobility Services Contributing to 65.31%

Infographics

×

2018 will see the first true deployment of automation where the vehicle will tell the driver with the first level 3 (L3) autonomous capability by taking the driver out of the loop to be introduced next year. Ironically, this may happen through a software patch update or a flagship generational product launch. Regardless of the medium through which ...

Connectivity is increasingly no longer an optional feature for vehicles. The automotive industry is in the midst of a massive transformation, where automakers are no longer hardware makers but are evolving into tech companies. The study aims to provide an insight into the challenges and technology innovations of the new decade that will transform t...

The CX landscape is changing rapidly. Organizations across the board are realizing the importance of delivering excellent customer service as a competitive differentiator. Hence, the domain is gaining more attention and greater investment priority. The market is also becoming much more tech-intensive as emerging tools are able to create a seamless ...

A growing demand for safety and convenience features has amplified the development and adoption of advanced driver assistance systems (ADAS) and autonomous driving (AD) features in passenger vehicles. Original equipment manufacturers seek to adopt level-2-and-above features in their mass-market vehicles to gain a competitive advantage. The United S...

Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition. Multiple drugs are at ...

07 Dec 2021  |  North America  |  Market Research

Global Autonomous Off-Highway Equipment Growth Opportunities

Cross-industry Collaboration, Bundling of Services, and Public and Private Sector Synergies will be Important

Infographics

×

The ability to handle extreme loads, continuous 24/7 operation, and safety are driving the development of autonomous technologies for off-highway equipment. Development of automation will move faster here than in the on-highway space mainly because of the standardized and often-isolated mining, construction, and agricultural operating environment c...

04 Sep 2018  |  North America  |  Market Research

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

Infographics

×

Key Issues Addressed

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...

Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...